1. |
Ley B, Brown KK, Collard HR. Molecular biomarkers in idiopathic pulmonary fibrosis. Am J Physiol Lung Cell Mol Physiol, 2014, 307(9): 681-691.
|
2. |
Wolters PJ, Collard HR, Jones KD. Pathogenesis of idiopathic pulmonary fibrosis. Annu Rev Pathol, 2014, 9: 157-179.
|
3. |
Raghu G, Collard HR, Egan JJ, et al. An official ATS/ERS/JRS/ALAT statement: idiopathic pulmonary fibrosis: evidence-based guidelines for diagnosis and management. Am J Respir Crit Care Med, 2011, 183(6): 788-824.
|
4. |
Lu Y, Azad N, Wang L, et al. Phosphatidylinositol-3-kinase/Akt regulates bleomycin-induced fibroblast proliferation and collagen production. Am J Respir Cell Mol Biol, 2010, 42(4): 432-441.
|
5. |
Du R, Xia L, Ning X, et al. Hypoxia-induced Bmi1 promotes renal tubular epithelial cell-mesenchymal transition and renal fibrosis via PI3K/Akt signal. Mol Biol Cell, 2014, 25(17): 2650-2659.
|
6. |
Qin J, Xie YY, Huang L, et al. Fluorofenidone inhibits nicotinamide adeninedinucleotide phosphate oxidase via PI3K/Akt pathway in the pathogenesis of renal interstitial fibrosis. Nephrology (Carlton), 2013, 18(10): 690-699.
|
7. |
马爱平, 高云周, 兰文斌, 等. PI3K/Akt/HIF-1α 信号通路在博来霉素诱导小鼠肺纤维化中的作用机制研究. 中国呼吸与危重监护杂志. 2016, 15(1): 34-38.
|
8. |
Bar-Peled L, Chantranupong L, Cherniack AD, et al. A Tumor suppressor complex with GAP activity for the Rag GTPases that signal amino acid sufficiency to mTORC1. Science, 2013, 340(6136): 1100-1106.
|
9. |
Thoreen CC, Chantranupong L, Keys HR, et al. A unifying model for mTORC1-mediated regulation of mRNA translation. Nature, 2012, 485(7396): 109-113.
|
10. |
Ashcroft T, Simpson JM, Timbrell V. Simple method of estimating severity of pulmonary fibrosis on a numerical scale. J Clin Pathol, 1988, 41(4): 467-470.
|
11. |
Ben-Sahra I, Manning BD.mTORC1 signaling and the metabolic control of cell growth. Curr Opin Cell Biol, 2017, 45: 72-82.
|
12. |
Kim SG, Buel GR, Blenis J. Nutrient regulation of the mTOR complex 1 signaling pathway. Mol Cells, 2013, 35(6): 463-73.
|
13. |
Dibble CC, Manning BD. Signal integration by mTORC1 coordinates nutrient input with biosynthetic output. Nat Cell Biol, 2013, 15(6): 555-64.
|
14. |
Gao Y, Xu X, Ding K, et al. Rapamycin inhibits transforming growth factor beta1-induced fibrogenesis in primary human lung fibroblasts. Yonsei Med J, 2013, 54(2): 437-444.
|
15. |
Park JS, Park HJ, Park YS, et al. Clinical significance of mTOR, ZEB1, ROCK1 expression in lung tissues of pulmonary fibrosis patients. BMC Pulm Med, 2014, 14: 168.
|
16. |
Madala SK, Thomas G, Edukulla R, et al. p70 ribosomal S6 kinase regulates subpleural fibrosis following transforming growth factor-alpha expression in the lung. Am J Physiol Lung Cell Mol Physiol, 2016, 310(2): 175-186.
|
17. |
Buschhausen L, Kamm M, Arns W, et al. Successful treatment of a severe case of idiopathic pulmonary fibrosis with rapamycin. Med Klin (Munich), 2005, 100(3): 161-164.
|
18. |
Gui YS, Wang L, Tian X, et al. mTOR Overactivation and Compromised Autophagy in the Pathogenesis of Pulmonary Fibrosis. PLoS One, 2015, 10(9): e0138625.
|